Gene expression profiling refers to the process of measuring the activity (expression) of several genes at once in to understand the cellular functions. This analysis can facilitate scientists to identify the molecular basis of phenotypic differences and also enables selection of gene expression targets for the future research studies. The various analysis techniques employed for gene expression are SAGE (serial analysis of gene expression), Real Time PCR-based gene expression profiling, microarray analysis, transcriptome sequencing and others. Gene expression reagents are the chemicals used in gene expression studies performed to determine the gene expression patterns. Sample preparation and isolation kits, sample labeling and amplification kits, TaqMan Gene Expression assay kits, gene expression hybridization kits and others are some of the examples of the commercially available gene expression reagents kits. Confirmation of appropriate gene expression is essential in order to ensure normal functioning of genes and any deviation from the normal expression pattern might result in the development of some disorder either genetic or acquired. Also, regulation of faulty gene expression inhibits the production of faulty functional products. For example, in case of cancer patients, RNA silencing is employed that includes the silencing of the cancerous gene expression.
The market for gene expression reagents can be analyzed on the basis of the reagents used in gene expression profiling along with application areas and geography. The reagents can be further segmented into the reagents used in PCR, Microarray, SAGE and others. The application areas that can be covered are drug discovery and research, biomarkers identification, clinical diagnostics and others. Geographically the market can be analyzed on the basis of four major regions namely North America, Asia-Pacific, Europe and RoW.
The major factors favoring the growth of the market are consistent technological advances, increased intensity of research and development activities and development of gene expression databases across the globe. In addition, increased investments and funding by the government for genetic research along with elevated awareness levels further propel the market growth. On the other hand, high instrumentation costs along with lack of technical expertise in this field would impede the growth of the market. Owing to several advantages and increasing preference for personalized medicine, the scope for growth and uptake of gene expression studies will also increase and in turn increase uptake of gene expression reagents. Affymetrix, Inc., Illumina, Inc., Qiagen N.V., Thermo Fisher Scientific (Life Technologies Corporation), Bio-Rad Laboratories, Inc. and Agilent Technologies are some of the companies competing in gene expression reagents market.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.